Author:
Beverly Raney R.,Maurer H.M.
Reference24 articles.
1. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk RMS: COG study D9803;Arndt;Journal of Clinical Oncology,2009
2. Prognostic factors and clinical outcomes in children and adolescents with metastatic RMS—a report from the intergroup RMS study IV;Breneman;Journal of Clinical Oncology,2003
3. Intergroup RMS study-IV: Results for patients with nonmetastatic disease;Crist;Journal of Clinical Oncology,2001
4. The third intergroup RMS study;Crist;Journal of Clinical Oncology,1995
5. RMS: Many similarities, a few philosophical differences;Donaldson;Journal of Clinical Oncology,2005